Clinical Observation of Recombinant Human Vascular Endostatin Durative Transfusion Combined with Window Period Arterial Infusion Chemotherapy in the Treatment of 
Advanced Lung Squamous Carcinoma

Background and objective Lung cancer is one of the most common malignant tumors in China. The aim of this study is to observe the efficacy and safety of recombinant human vascular endostatin (endostar) durative transfusion combined with window period arterial infusion chemotherapy in the treatment o...

Descripció completa

Dades bibliogràfiques

Autors principals:	Yuan LV, Rong JIANG, Chunhua MA, Jinduo LI, Bin WANG, Liwei SUN, Ning MU
Format:	Artigo
Idioma:	Chinês
Publicat:	Chinese Anti-Cancer Association; Chinese Antituberculosis Association 2015-08-01
Col·lecció:	Chinese Journal of Lung Cancer
Matèries:	Lung neoplasms Recombinant human vascular endostatin Arterial infusion chemotherapy Adverse reactions
Accés en línia:	http://dx.doi.org/10.3779/j.issn.1009-3419.2015.08.05
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!